Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Pre-Close Period Statement

14 Jul 2006 07:00

Gyrus Group PLC14 July 2006 14th July 2006 Gyrus Group PLC Pre-Close Period Statement Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices whichreduce trauma and complications in surgery, today provides a pre-close periodupdate ahead of its interim results announcement on 12th September 2006. The Group's reported revenues for the six months to 30th June 2006 areanticipated to be approximately £107 million representing growth of over 125% onthe previous year (2005: £47.3 million). Proforma organic revenue growth (whichassumes a full period comparative for the ACMI business which was acquired on21st July 2005) is expected to be marginally over 10%. The legacy Gyrusbusinesses grew revenue by approximately 17% over the first half of 2005 (12% ona constant exchange rate basis). Good performances from the Group's proprietaryDivisions in the US and the Partnered Technologies Division were partly offsetby a weaker performance in international markets, where the integration ofinternational distributors during the period caused a shortfall in revenues. The Surgical Division's new PlasmaCision-derived products (G400 generator,Plasma Trissector, Plasma J Hook) were introduced to the general surgery marketin late March and the technology has been well received during this initialevaluation phase. At the end of the period there were approximately 100 G400generators either placed or sold into the surgical market and the divisionachieved revenue in excess of $1 million from the PlasmaCision portfolio. The Urology & Gynaecology Division had a slower first half when compared to astrong 2005 result pre-acquisition, however the adoption of PK SuperPulse intothe legacy ACMI urology accounts has started well with sales in excess of theCompany's forecasts. New product introductions, including the early evaluationof the new digital ureteroscope, show significant potential for the second halfof 2006. The integration programme has continued on track and savings from this, togetherwith revenue orientated towards more profitable US domestic disposables sales,is expected to result in a significant enhancement to operating profitability. Subject to any unforeseen adjustments it is anticipated that underlying "adjusted" earnings per share (excluding amortisation of acquired intangibleassets, integration costs and deferred tax adjustments) for the six months to30th June 2006 will be in line with consensus expectations, which currentlystand at 7.3 pence per share (H1 2005: 5.1 pence). Brian Steer, Executive Chairman of Gyrus said: "The first half of 2006 has been a successful period of change; we have madesignificant inroads into the integration programme and have started tore-orientate the legacy ACMI business towards our disposable devices businessmodel. At the same time we have successfully introduced our important newPlasmaCision technology. In addition, we look forward to a number of potentiallysignificant new product launches in the second half of 2006." Enquiries: Gyrus Group PLCBrian Steer Executive Chairman 01189 219 750Simon Shaw Chief Financial Officer 01189 219 750 Financial DynamicsBen Atwell 0207 269 7242 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Apr 20214:41 pmRNSForm 8.5 (EPT/RI)
13th Apr 20212:33 pmBUSForm 8.3 - GYG PLC
13th Apr 20211:35 pmRNSForm 8.3 - GYG Plc
13th Apr 20217:00 amRNSStatement re:Nobiskrug Shipyard & delay to Results
12th Apr 20217:00 amRNSResponse to Harwood Announcement
9th Apr 20214:36 pmRNSStatement re: Possible Offer for GYG plc
9th Apr 20219:00 amRNSNotice of Results and Investor Presentation
29th Mar 202112:19 pmRNSHolding(s) in Company - replacement
22nd Mar 20216:27 pmRNSHolding(s) in Company
9th Mar 20212:48 pmRNSHolding(s) in Company
17th Feb 20211:11 pmRNSHolding(s) in Company
2nd Feb 20217:00 amRNSFull Year Trading Update
22nd Jan 20214:00 pmRNSHolding(s) in Company
21st Jan 20212:26 pmRNSHolding(s) in Company
20th Jan 20219:54 amRNSHolding(s) in Company
20th Jan 20219:50 amRNSHolding(s) in Company
20th Jan 20219:45 amRNSHolding(s) in Company
15th Dec 20207:00 amRNSNew Spray Filler Application on New Build Project
10th Dec 20207:00 amRNSRefit Contract Signed
9th Dec 20206:11 pmRNSPurchase of Own Shares
22nd Oct 20203:54 pmRNSPurchase of Own Shares
22nd Oct 20207:00 amRNSSignificant Refit Contract Signed
21st Oct 20203:36 pmRNSPurchase of Own Shares
1st Oct 20207:00 amRNSChange of Nominated Adviser and Broker
24th Sep 20207:00 amRNS2020 Interim Results
18th Sep 20207:00 amRNSNew Build Letter of Intent signed
2nd Sep 202011:00 amRNSResult of General Meeting (“AGM”)
21st Aug 20207:00 amRNSHalf Year Trading Update
20th Aug 20209:00 amRNSPDMRs
31st Jul 20203:52 pmRNSANNUAL REPORT AND NOTICE OF GENERAL MEETING
22nd Jul 20207:00 amRNSFinal Results
17th Jul 20201:54 pmRNSHolding(s) in Company
17th Jul 20207:00 amRNSNotice of Results
30th Jun 202010:53 amRNSResult of Annual General Meeting
29th Jun 20207:00 amRNSExtension for Publication of Accounts & AGM update
17th Jun 20204:37 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSTwo Refit Contracts Signed with MB92 Group
5th Jun 20207:00 amRNSNotice of AGM, Annual Report & Final Results
12th May 20204:21 pmRNSHolding(s) in Company
28th Apr 20203:00 pmRNSHolding(s) in Company
15th Apr 20207:00 amRNSBank Facilities Amendment and Activities Update
26th Mar 20207:00 amRNSCOVID-19 Update
25th Mar 202011:36 amRNSHolding(s) in Company
24th Mar 20201:56 pmRNSHolding(s) in Company
16th Mar 202011:28 amRNSHolding(s) in Company
12th Feb 20206:05 pmRNSHolding(s) in Company
12th Feb 20205:17 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSFull Year Trading Update and Notice of Results
22nd Jan 202011:46 amRNSTR-1: Standard form notification of major holdings
8th Jan 20205:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.